Extracorporeal membrane oxygenation market

Extracorporeal Membrane Oxygenation System Market, by Modality (Arteriovenous, Venoarteial, and Venovenous) by Application (Extracorporeal cardiopulmonary resuscitation, Cardiac, and Respiratory), by Age Group (Neonatal, Pediatric, and Adults), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2030

Request Free Sample

Jul 2022
CMI947
170 Pages
Excel & Pdf
Medical Devices

Summary

Extracorporeal membrane oxygenation (ECMO) system is a life supporting system providing cardiac and respiratory support to the patients suffering from severe respiratory failure. ECMO circuit comprises cannulas, pump, blender and oxygenator, which oxygenates the blood and remove carbon dioxide through extracorporeal gas exchange device referred to as membrane oxygenator. Potential indications for which ECMO is used includes severe acute respiratory distress syndrome (ARDS), acute hypercapnic respiratory failure, bridge lung transplantation, primary graft dysfunction post-lung transplantation, and pulmonary hypertension with right ventricular failure.

Global extracorporeal membrane oxygenation system market is estimated to be valued at US$ 316.5 million in 2022 and is expected to exhibit a CAGR of 5.3% during the forecast period (2022-2030).

Figure 1.Global Extracorporeal Membrane Oxygenation System Market Share (%), by Modality, 2022

Increasing prevalence of cardiovascular and respiratory disorders are expected to drive growth of the extracorporeal membrane oxygenation system market

Increasing cases of cardiovascular and respiratory disorders is one of the major factors that is boosting growth of the extracorporeal membrane oxygenation system (ECMO) system market. For instance, according to data provided by the Centers for Disease Control and Prevention, in February 2022, one person dies every 36 seconds in the U.S. from cardiovascular disease.

Extracorporeal Membrane Oxygenation System Market Report Coverage

Report Coverage	Details
Base Year:	2021	Market Size in 2022:	US$ 316.5 Mn
Historical Data for:	2017 to 2020	Forecast Period:	2022 to 2030
Forecast Period 2022 to 2030 CAGR:	5.3%	2030 Value Projection:	US$ 476.8 Mn
Geographies covered:	North America: U.S. and Canada Latin America: Brazil, Argentina, Mexico, and Rest of Latin America Europe: Germany, U.K., Spain, France, Italy, Russia, and Rest of Europe Asia Pacific: China, India, Japan, Australia, South Korea, ASEAN, and Rest of Asia Pacific Middle East: GCC Countries, Israel, and Rest of Middle East Africa: South Africa, North Africa, and Central Africa
Segments covered:	By Modality: Arteriovenous, Venoarteial, Venovenous By Application: Extracorporeal cardiopulmonary resuscitation, Cardiac, Respiratory By Age Group: Neonatal, Pediatric, Adults
Companies covered:	Medtronic, Getinge AB, LivaNova PLC, Terumo Corporation, XENIOS AG, OriGen Biomedical, EUROSETS NIPRO, and MicroPort Scientific Corporation
Growth Drivers:	Increasing prevalence of cardiovascular and respiratory disorders Industrial collaborations by key players in market
Restraints & Challenges:	Complications associated with the ECMO system such as internal bleeding, blood clotting or technical failure High cost of ECMO equipments

Figure 2.Global Extracorporeal Membrane Oxygenation System Market Share (%), by Region, 2022

Industrial collaborations by key players in market are expected to drive market growth during the forecast period.

Industry players in market are adopting the strategy of collaboration focusing on development of products. For instance, in 2018, Medtronic, a leader in medical technology, services, and solutions, collaborated with Sayler Biomedical LLC, for development of the product Century heart Lung machine. Century heart lung machine has features, such as compact and sturdy design, easy to use components and affordable price.

Global Extracorporeal Membrane Oxygenation System Market– Impact of Coronavirus (COVID-19) Pandemic

Since the COVID-19 virus outbreak in December 2019, the disease has spread to over 100 countries across the globe and the World Health Organization had declared it a public health emergency on January 30, 2020.

The COVID-19 pandemic had a positive impact on the global extracorporeal membrane oxygenation system market, owing to its use in patients infected with the COVID-19 infection, experiencing difficulty in breathing. For instance, in April 2020, the U.S. Food and Drug Administration (FDA) had issued guidance to provide a policy to help expand the availability of devices used in extracorporeal membrane oxygenation (ECMO) therapy to address the novel coronavirus (COVID-19, SARS-CoV-2) public health emergency. ECMO systems are used for long-term respiratory/cardiopulmonary failure and provide assisted extracorporeal circulation and physiologic gas exchange of the patient’s blood for more than six hours. The technology can oxygenate a severely sick COVID-19 pneumonia patient's blood without the need to transfer oxygen through fluid filled lungs. Thus the COVID-19 pandemic had a positive impact on the extracorporeal membrane oxygenation system market

Global Extracorporeal Membrane Oxygenation System Market: Key Developments

In May 2022, LivaNova PLC, a global medical technology company, acquired ALung Technologies, Inc., the leading provider of low-flow extracorporeal carbon dioxide removal (ECCO2R) technologies for treating patients with acute respiratory failure

In January 2021, Braile Biomedica, an advanced manufacturer of medical-surgical and hospital products, launched SOLIS System, a product against COVID-19 in partnership with the Eldorado Institute, a non-profit research, development and innovation institution, and Embrapii, a social organization. The system consists of extracorporeal membrane oxygenation (ECMO), a form of extracorporeal breathing.

Global Extracorporeal Membrane Oxygenation System Market: Restraint

The major factors that hinder growth of the global extracorporeal membrane oxygenation system market include complications associated with the ECMO system such as internal bleeding, blood clotting or technical failure and high cost of the ECMO equipments.

Key Players

Major players operating in the global extracorporeal membrane oxygenation system market include Medtronic, Getinge AB, LivaNova PLC, Terumo Corporation, XENIOS AG, OriGen Biomedical, EUROSETS NIPRO, and MicroPort Scientific Corporation.

Table of Content

Table of Contents

*Browse 36 market data tables and 32 figures on "Extracorporeal Membrane Oxygenation System Market” - Global forecast to 2030

Segmentation

Detailed Segmentation:

- Frequently Asked Questions -

What is the current market size and compound annual growth rate (CAGR) of the global extracorporeal membrane oxygenation system market during the forecast period (2022-2030)?

Global extracorporeal membrane oxygenation system market size is estimated to be valued at US$ 316.5 million in 2022 and is expected to exhibit a CAGR of 5.3% between 2022 and 2030.

What are the major factors driving the market growth?

Factors such as increasing prevalence of cardiovascular and respiratory disorders and industrial collaborations by key players in market are expected to drive the market growth.

Which is the leading application segment in the market?

Respiratory is the leading application segment in the market.

What are the key factors hampering growth of the market?

The major factors hampering growth of the market include complications associated with the ECMO system such as internal bleeding, blood clotting or technical failure and high cost of the ECMO equipments

Which are the major players operating in the market?

Major players operating in the market include Medtronic, Getinge AB, LivaNova PLC, Terumo Corporation, XENIOS AG, OriGen Biomedical, EUROSETS NIPRO, and MicroPort Scientific Corporation.